Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Description
Blood-brain barrier leakage in patients with early Alzheimer disease
Stable Therapy: Use may be considered with caution for patients on stable endocrine-based therapies, provided there is close monitoring
BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
Eur J Clin Investig 22:204209 Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER (1989) Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man
Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades
US$ 28.28
US$ 21.50
US$ 20.54
